The RET/PTC3 transgenic mice model, in which the expression of the RET/PTC3 oncogene is targeted to the thyroid and which develops a solid variant of papillary thyroid carcinoma, represents a suitable model of human PTC [57,58]. This evidence concerns the gene RET and thyroid gland papillary carcinoma.